MSR79 Evaluation of Real-World Response Rate in Clinical Trial-Aligned Cohorts of Patients With Lung, Colon, and Breast Cancer Using Machine Learning
Qiushi Zhang(Guangdong Provincial People's Hospital), Kelly Magee(Flatiron Health (United States)), Erin Fidyk(Flatiron Health (United States)), Aaron B. Cohen(Flatiron Health (United States)), Niquelle Brown Wadé(Flatiron Health (United States)), Sheila Nemeth(Flatiron Health (United States)), Eunsil Yim(Flatiron Health (United States)), Auriane Blarre(Flatiron Health (United States)), M. Wang(Flatiron Health (United States)), Konstantin Krismer(Massachusetts Institute of Technology), Aaron Dolor(Flatiron Health (United States)), Xiaofeng Wang(Virginia Tech), Qian Yuan(Huazhong University of Science and Technology), Tony Williams(Flatiron Health (United States)), M Richey(Flatiron Health (United States)), Cliff Fullerton(Flatiron Health (United States)), Prabahita Baruah(Flatiron Health (United States)), S P Wilkinson(Flatiron Health (United States)), Nirmala Singh(Flatiron Health (United States))
Cited by 1
Related Papers
ESCRT-III–dependent membrane repair blocks ferroptosis
|Biochemical and Biophysical Research Communications|2019|267
A Large-Scale Binding and Functional Map of Human RNA Binding Proteins
|bioRxiv (Cold Spring Harbor Laboratory)|2017|187
Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness
|Carcinogenesis|2011|177
Host Lipids in Positive-Strand RNA Virus Genome Replication
|Frontiers in Microbiology|2019|155